Innate Pharma S.A. (NASDAQ:IPHA) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for joining, and welcome to the Innate Pharma First Quarter 2026 Business Update and Financial Results.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lion Point Didric Cederholm | 81,151 | $103,873 | 0.62% | |
| 2. | Millennium Management Israel Englander | 10,064 | $12,882 | -51% | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,750 | $43,700 | 0.01% | |
| 2. | 21 | $38 | 0% | |
| 3. | 9 | $17 | 0% | |
| 4. | 0 | $0 | 0% |